Advanced Solid Malignancies Clinical Trials

59 clinical trials for Advanced Solid Malignancies across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies — RECRUITING · PHASE1
• A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies — RECRUITING · PHASE1
• Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors — RECRUITING · PHASE1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies — RECRUITING · PHASE1
• Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies — RECRUITING · PHASE1
• A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors — RECRUITING · PHASE1
• Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib — ACTIVE_NOT_RECRUITING · PHASE1
• A trial to learn how saruparib works and how safe it is in the bodies of adults with advanced solid tumors — TERMINATED · PHASE1
• Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies — TERMINATED · PHASE1
• Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies — COMPLETED · PHASE1
• Human ADME Study of [14C]-AZD1390 — NOT_YET_RECRUITING · PHASE1
• Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER) — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies — SUSPENDED · PHASE1
• Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies — ACTIVE_NOT_RECRUITING · PHASE1
• Japanese Phase I Study of AZD2014 in Advanced Solid Malignancies — COMPLETED · PHASE1
• An Open-Label Phase 1 Study of Ceralasertib in Japanese Patients With Advanced Solid Malignancies — COMPLETED · PHASE1
• Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid Malignancies — COMPLETED · PHASE1
• A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies — COMPLETED · PHASE1
• An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies. — COMPLETED · PHASE3
• A Study to Evaluate the Safety, Tolerability and How YH002 Enters, Moves Through and Exits the Body in Subjects With Advanced Solid Malignancies — COMPLETED · PHASE1
• A Phase I Open-label Study for Subjects With Advanced Malignancies — OTHER · PHASE1
• Absorption, Distribution, Metabolism and Excretion (ADME) Study of TKI258 in Patients With Advanced Solid Malignancies — COMPLETED · PHASE1
• A Phase I Study of AZD4635 in Japanese Patients With Advanced Solid Malignancies — COMPLETED · PHASE1
• A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Dose Escalation Study of MLN0128 in Participants With Advanced Malignancies — COMPLETED · PHASE1
• Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies — COMPLETED · PHASE1
• A Phase I Study of MEDI9447 (Oleclumab) in Japanese Patients — COMPLETED · PHASE1
• Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas — COMPLETED · PHASE1
• Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid Malignancies — COMPLETED · PHASE1
• A Phase I Study of Fluzoparib in Patient With Advanced Solid Malignancies — COMPLETED · PHASE1
• A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline — TERMINATED · PHASE1
• Dose-Seeking Study of MPT0E028 in Subjects With Advanced Solid Malignancies Without Standard Treatment — COMPLETED · PHASE1
• Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours — TERMINATED · PHASE1
• Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies — COMPLETED · PHASE1
• A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies — COMPLETED · PHASE1
• Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer — COMPLETED · PHASE1
• Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours — COMPLETED · PHASE1
• Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient — COMPLETED · PHASE1
• Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014 — COMPLETED · PHASE1
• Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma — COMPLETED · PHASE1
• Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese Subjects — COMPLETED · PHASE1
• A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies — COMPLETED · PHASE1
• Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102) — COMPLETED · PHASE1
• Study of AZD8931 in Patients With Advanced Solid Malignancies — COMPLETED · PHASE1
• A Study of MEDI-575 in Patients With Advanced Solid Malignancies — COMPLETED · PHASE1
• A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase. — TERMINATED · PHASE1
• Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies — COMPLETED · PHASE1
• A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid Malignancies — COMPLETED · PHASE1

Refine this search